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Abstract
Background: Existing guidance for developing public health interventions does not provide information for researchers
about how to work with intervention providers to co-produce and prototype the content and delivery of new
interventions prior to evaluation. The ASSIST + Frank study aimed to adapt an existing effective peer-led smoking
prevention intervention (ASSIST), integrating new content from the UK drug education resource Talk to Frank
(www.talktofrank.com) to co-produce two new school-based peer-led drug prevention interventions. A three-stage
framework was tested to adapt and develop intervention content and delivery methods in collaboration with key
stakeholders to facilitate implementation.
Methods: The three stages of the framework were: 1) Evidence review and stakeholder consultation; 2) Co-production;
3) Prototyping. During stage 1, six focus groups, 12 consultations, five interviews, and nine observations of intervention
delivery were conducted with key stakeholders (e.g. Public Health Wales [PHW] ASSIST delivery team, teachers, school
students, health professionals). During stage 2, an intervention development group consisting of members of the research
team and the PHW ASSIST delivery team was established to adapt existing, and co-produce new, intervention activities. In
stage 3, intervention training and content were iteratively prototyped using process data on fidelity and acceptability to
key stakeholders. Stages 2 and 3 took the form of an action-research process involving a series of face-to-face meetings,
email exchanges, observations, and training sessions.
Results: Utilising the three-stage framework, we co-produced and tested intervention content and delivery methods for
the two interventions over a period of 18 months involving external partners. New and adapted intervention activities, as
well as refinements in content, the format of delivery, timing and sequencing of activities, and training manuals resulted
from this process. The involvement of intervention delivery staff, participants and teachers shaped the content and format
of the interventions, as well as supporting rapid prototyping in context at the final stage.
Conclusions: This three-stage framework extends current guidance on intervention development by providing step-by-
step instructions for co-producing and prototyping an intervention’s content and delivery processes prior to piloting and
formal evaluation. This framework enhances existing guidance and could be transferred to co-produce and prototype
other public health interventions.
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Background
There are a range of approaches to public health inter-
vention development [1–12]. The UK’s Medical Research
Council (MRC) guidance, the most widely cited
approach, recommends that intervention development
should consist of theory development, identification of
an evidence base (typically through a recent or new sys-
tematic review), and modelling of processes and out-
comes [13]. Other approaches provide more detailed
guidance on: developing intervention or program theory
[2, 6, 9]; using mapping techniques to inform the com-
ponents required in an intervention [1, 5, 7, 10]; cycles
of testing and refinement [3, 8] and the use of partner-
ships with individuals, communities, and service
providers [4, 7, 8, 12]. These guidelines support develop-
ment of a theoretical rationale for an intervention, but
provide scant pragmatic instruction on how to develop
intervention materials and delivery methods.
Theory needs to be translated into intervention design
in a way that facilitates adoption across settings and
maximises implementation. The RE-AIM framework
helped to re-focus away from efficacy to effectiveness,
and assess the degree of reach, adoption, implementa-
tion and maintenance of effects [14]. As well as identify-
ing reasons for (in)effectiveness, an assumption is that
barriers to adoption, implementation and maintenance
that are identified in evaluations are addressed in the
adaptation of existing or design of new interventions. It
is not clear whether this occurs. Even if barriers are ad-
dressed, as the policy and practice landscape can change
with country, health system and time, some barriers
identified may not be relevant in a new system. A
method for the rapid identification of potential barriers
to effectiveness, possible solutions, testing and re-testing
of materials would save the costly implementation of in-
terventions that do not adequately account for variations
in context. The involvement of customers in the
prototyping of new products has long been used in
manufacturing [15], as a method for gaining feedback
and improving design. Intervention design may bene-
fit from incorporating the principles of iterative product
development and testing intervention components, or
prototyping, with those who deliver and receive inter-
ventions [16].
The concept of Transdisciplinary Action Research
(TDAR) [12] has been developed to support effective
collaboration between behavioural researchers, policy
makers, frontline public services staff and communities.
Building on Lewin’s [17] concept of ‘action research’ that
combines scientific and societal value, TDAR is an ap-
proach where researchers from multiple disciplines work
with a range of stakeholders and intended beneficiaries
to jointly understand social problems and identify prac-
tical solutions to them, such as through co-producing
new public health interventions [5]. A key component of
this approach to applied social science is the develop-
ment of sustainable, replicable processes to support
effective collaboration between researcher teams, front-
line practitioners and communities in order to harness
the latent expertise of key stakeholders (for example,
those who deliver health promotion to the target popu-
lation, gatekeepers within settings such as school
teachers, managers, owners) so that the acceptability and
feasibility of the intervention is addressed and maxi-
mised at the development stage [5, 12, 18–20].
We present the framework for co-production and
prototyping which was used to guide the adaptation of the
ASSIST smoking prevention intervention to develop de-
tailed content and delivery processes for two new peer-led
drug prevention interventions, one as an adjunct to the
ASSIST intervention (+Frank) and the other a standalone
drug prevention intervention (Frank friends).
Case study: ASSIST + Frank intervention development study
Informed by the principles of TDAR, we tested a novel,
staged approach to adapt and co-produce with stake-
holders the content and delivery of two new informal,
peer-led interventions to prevent illicit drug use among
secondary-school students in the United Kingdom by
adapting an effective peer-led smoking prevention inter-
vention (ASSIST) [21]. ASSIST is a school-based peer-
led intervention that has been shown to be effective in
reducing the uptake of smoking in UK secondary
schools [21]. It is recommended in the National Institute
for Health and Care Excellence (NICE) guidance on
school-based smoking prevention [22] and forms part of
the Welsh and Scottish Governments’ tobacco harm re-
duction plans [23, 24]. In contrast, studies of the imple-
mentation and effectiveness of peer-led drug prevention
interventions report mixed evidence [25–27]. For ex-
ample, very low-levels of implementation occurred in
the EU-Dap trial, where only 8% of centres imple-
mented all seven peer-led sessions and 71% did not
conduct any meetings at all [26]. Moreover, there is
some evidence of harmful effects for school students
with drug using friends from the US TND-Network
trial [27]. These challenges suggested new approaches
were warranted and more careful intervention devel-
opment was required.
Informed directly by the existing evidence surrounding
the effectiveness of the ASSIST intervention [21] and its
basis in the theory of Diffusion of Innovations [28], we
adapted the ASSIST model of informal peer-led delivery
(see Additional file 1: Table S1 for components of
ASSIST) to drug prevention using information from the
UK national drug education website, Talk to Frank [29].
The theoretical basis and design of the effective ASSIST
intervention informed a skeleton structure of core
Hawkins et al. BMC Public Health  (2017) 17:689 Page 2 of 11
intervention components and processes that under-
pinned the development of the two new informal, peer-
led interventions to prevent illicit drug use. From this,
an intervention logic model was constructed for each of
the two new peer-led drug prevention interventions,
+Frank and Frank friends (see Additional file 1: Figs. S1
and S2), which would be compared at subsequent stages
of evaluation.
The intervention “+Frank” is as an informal peer-led
drug prevention adjunct to the ASSIST smoking preven-
tion intervention. It is designed to be delivered in sec-
ondary schools to year 9 students (aged 13–14) who
have previously received ASSIST in year 8. “Frank
friends” is a stand-alone, informal drug prevention inter-
vention. It aims to identify and recruit peer opinion
leaders in year 9 to be trained as peer supporters. Both
interventions involve off-site training to learn the effects
and risks associated with specific drugs and potential
harms; +Frank involves one day and Frank friends two
days of training. Peer supporters are asked to have con-
versations with their peers on the risks of different drugs
and log these interactions over 10-weeks. +Frank peer
supporters are visited three times and Frank friends four
times by trainers to support them to have conversations.
Methods
A three stage multi-method framework was tested to co-
produce the content, resources, and delivery methods
for the +Frank and Frank friends interventions based on
their logic models. The three stages are: 1) Evidence re-
view and stakeholder consultation; 2) Co-production;
and 3) Prototyping. The methods used at each stage
allowed for integration of scientific literature with stake-
holders’ knowledge and expertise. The key stakeholders
in intervention development were the Public Health
Wales (PHW) ASSIST delivery team, secondary school
students, and health professionals working for drug
agencies and with young people. The objectives of the
methods used and topics explored at each stage are
summarised in Additional file 1: Table S2.
Stage one: Evidence review and stakeholder consultation
In stage one, ‘evidence review and stakeholder consult-
ation’, members of the research team engaged in a
process of co-operative enquiry with stakeholders. A var-
iety of consultation methods were offered to groups of
stakeholders to enable them to participate in the way
that they felt was most appropriate. The overall aim of
the stakeholder consultation was to gather multiple per-
spectives about drug use issues relevant to young people,
existing drug education for young people, and ideas for
appropriate and acceptable content for the peer-led drug
interventions. This involved a range of methods.
Focus groups with young people
Six focus groups were conducted with 47 young people
aged 13–15 who were purposively sampled from a range
of settings allowing for variation in demographic back-
grounds and existing experience of drug use (three
schools, a youth centre and a student referral unit). A
semi-structured topic guide was used consisting of broad
open-ended questions relating to participatory task-
based activities using information and resources from
Talk to Frank.
Interviews with the ASSIST intervention delivery team
Interviews were conducted with an opportunity sample
of five members of the PHW ASSIST delivery team.
Observations of current practice
Observations of all five stages of ASSIST intervention
delivery were conducted (n = 8) as well as one observa-
tion of the ASSIST ‘Train the Trainers’ course.
Stakeholder consultation
A range of unstructured consultations were also con-
ducted with opportunity samples of young people and
practitioners: one with five volunteers from a young
people’s public involvement group (ALPHA) aged 16–
19 years old; one with seven young people aged 13–15;
one with five recipients of ASSIST aged 12–13; and nine
individual consultations with health professionals work-
ing for drug agencies (n = 4) or with young people
(n = 4) or both (n = 1).
Audio recordings of the focus groups and interviews
were transcribed verbatim and analysed using thematic
analysis. An a priori coding framework focused on the
objectives of the interviews with the delivery team was
applied to the interview transcripts to organise data for
subsequent searches for recurring patterns and themes.
However, an element of flexibility was maintained such
that codes which did not fit the framework were also
captured. This analysis approach has been described in
detail elsewhere [30].
Researcher field notes from observations and informal
consultations were collated and combined with the out-
comes from the analysis of interview and focus group
data in order to identify similarities and differences
across the various stakeholder perspectives emerging
from the consultation process. These outcomes were
then taken forward to feed into the co-production of
intervention content during stage 2.
Stage two: Co-production
In stage 2, ‘co-production’, an intervention development
group consisting of members of the research team and
key stakeholders was established to co-produce the inter-
vention materials and resources. The key stakeholders
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identified for adapting the ASSIST intervention to deliver
information from Frank were members of the Public
Health Wales ASSIST delivery team. The PHW team had
delivered ASSIST to over 350 schools over a period of
seven years so had extensive experience of intervention
delivery within schools and were well placed to consider
the potential feasibility of adapting intervention content
for use with an older age group and for drug preven-
tion. The team had also been identified to deliver the
new drug prevention interventions that were being
developed.
Co-production of intervention content took the form
of an action research cycle over a series of meetings of
the intervention development group in which findings
from stage 1 were considered, ideas were presented by
all members, feedback on ideas sought, refinements
made and presented again, until final content was
agreed. Five face-to-face meetings were held over the
course of a four month period. These were supple-
mented by communications via email where face-to-face
meetings were not possible, or when matters arose that
required discussion between meetings.
Stage three: Prototyping
In stage 3, ‘prototyping’, the draft intervention manuals
and associated resources underwent expert review by
the lead author of the ASSIST randomised controlled
trial [21], and the lead trainer of DECIPHer Impact, the
company that licenses ASSIST. Reviewers looked over
the adaptations made to ASSIST intervention content
and resources, as well as newly developed content, and
were asked to provide feedback regarding key uncertain-
ties identified during development (for example, fit with
the Diffusion of Innovations theory, age-appropriateness
of activities, suitability of timings and sequencing).
In order to gain preliminary feedback regarding ac-
ceptability and feasibility of the intervention content,
intervention delivery was tested with an opportunity
sample of the ALPHA group (n = 5), as well as during
two training sessions with the intervention delivery
team. Independent observations of intervention delivery
in two test schools were made by two members of the
research team using a structured observation tool to
check whether the learning outcomes for each activity
were met and any deviations that were made.
Results
Figure 1 shows the framework and activities that were
completed in the ASSIST + Frank intervention develop-
ment study stage. The process of co-production and
prototyping took 18 months and comprised 42 activities
(Fig. S3 shows the frequency and time line of each activ-
ity). The process was iterative and cumulative with refine-
ments occurring prior to the next stage.
Stage one: Evidence review and stakeholder consultation
In line with the MRC guidance on developing complex
interventions [13], we reviewed the existing literature to
identify the existing distribution of illegal drug use
amongst young people and whether there were any
existing effective school-based drug prevention interven-
tions. A non-systematic review of population-based
prevalence studies with secondary school-aged children
in the United Kingdom (aged 11 to 16 years of age)
showed the lifetime prevalence of any illegal drug use
doubled from 6.8% to 12.4% then 23.1% between the
ages of 13, 14, and 15 years respectively [31], this in-
formed our decision to deliver the intervention to UK
year 9 students (13 to 14 years of age) as it an age of
rapidly increasing drug experimentation. A systematic
review of school-based drug prevention found small
effects on cannabis use in the short term and poor im-
plementation of interventions that were peer delivered
[25, 26]. The development of the +Frank and Frank
friends interventions was informed by the effectiveness
of the ASSIST intervention [21] and its basis in the the-
ory of Diffusion of Innovations [28], an approach not
previously used in relation to youth drug prevention.
During stage one we consulted with key stakeholders
with the aim of gathering information to tailor the inter-
ventions to the target context and population in order to
maximise acceptability and reduce problems with imple-
mentation. Key stakeholders were identified as people
with direct experience or knowledge of youth drug tak-
ing, recipients of the existing ASSIST smoking preven-
tion intervention, intended recipients of the newly
developed interventions, and those who delivered any
existing drug prevention interventions within the setting
(i.e. schools) or provided intervention resources (e.g.
financing, staffing).
Table 1 summarises the results from the stage one
focus groups, interviews, consultations and observations.
Several narratives were replicated across the different
stakeholders. With regard to which drugs the interven-
tion should prioritise, the young people aged 12–18,
practitioners working in drug support agencies with
young people, and the review of prevalence studies all
highlighted the same eight drugs which had over a 1%
prevalence in 13–15 year olds [31]. The consultations
with young people and practitioners also noted a local
issue with steroid use in older age groups, which was
not apparent in prevalence data as these were gathered
in England and did not sample from Welsh schools.
These consultations led us to tailor the intervention to
the local context by including information on steroids in
the interventions.
The consultations and focus groups with young people
suggested that 13 to 14 year olds were relatively familiar
with the potentially harmful effects of drugs on health.
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“Like we all know weed is bad, we all know what it
does to you as well.” [P1, male]
Young people were less familiar with the potential
legal consequences of being caught in possession of an
illegal drug in the UK.
“When it says unlimited fine, does that mean the police
can just charge you?” [P2, female]
The familiarity of young people with the harms of
drugs on health, prompted us to also add focus on the
harms associated with drugs being illegal and therefore
unregulated, such as unexpected effects brought about
by consuming an unknown compound of an unknown
dose. Other concerns that young people voiced included
the potential harms of drug use on family relationships,
future education and employment.
“I mean that’s your mum, that’s one of your parents,
they put a roof over your head. If you get drove away
from them you don’t get food for yourself, you don’t get
a roof over your head, you’re out on the streets. You
don’t have anyone to get you a meal or look after you
‘cause you’re on your own.” [P3, male]
“‘Cause then you’re getting a criminal record that’s
stopping you from getting a job and loads of stuff.”
[P4, female]
A number of factors that might influence the engagement
of students during peer supporter training were found in
both the interviews with the ASSIST delivery team and in-
dependent observations by the research team of delivery of
the intervention. In particular, the importance of flexibility
in delivery of intervention activities to different groups and
the need for engaging, interactive content.
“We work to the same objectives, but in terms of how we run
some activities, we might change them a bit … with different
groups you know, how they react to a certain activity you
might change it round to help the running of it.” [T1]
“I think it’s important that whatever we do that it’s quite
engaging and [students] get an input as well, you know,
not just sitting there watching us, listening to us, I think
it’s important that it’s interactive as well.” [T3]
“Making sure that they’re interactive … so they’re up
and about, they get moving around, break off activities,
um, just making it as interactive as possible.” [T4]
Fig. 1 Framework for intervention co-production and prototyping. a Stakeholders comprise those within or external to the delivery setting (e.g.
school-based: school teachers, head teacher, contact teacher, head of Personal, Social, Health and Economic (PSHE) education, head of year, receptionist;
national and local policy leads; parents/ guardians/ caregivers)
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Table 1 Results from application of the 3-stage framework for co-production and prototyping in the ASSIST + Frank study
Activity Objectives Results
Stage 1: Evidence review and stakeholder consultation
Evidence review Identify target age group for interventions
and identify target drugs to focus intervention
content on.
• The Smoking, Drinking and Drug Use survey in Young People
showed the use of any drug in the last year almost doubled
from 6.8% at age 13, to 12.4% at age 14, and then again to
23.7% at age 15; largely due to increases in the use of cannabis [31];
• Target intervention at 13–14 year olds (Year 9 students);
• Focus intervention content on drugs with >1% prevalence in
13–15 year olds (cannabis, volatile substances, ecstasy, poppers,
cocaine, ketamine, mephedrone, and magic mushrooms).
Consultation with young
people’s involvement group
Explore thoughts about drug education in
school, their conversations about drugs
with friends, awareness of Talk to Frank
and opinions of the website.
• Drug education is typically didactic and should be more interactive;
• Discussions with peers about drugs are frequent;
• Commonly used drugs at their age are alcohol, cannabis,
poppers, mephedrone, ketamine and cocaine;
• Talk to Frank was viewed positively, but should be accompanied
by other visual resources.
Consultation with Year
9 students
Explore views about drug use in their age
group and ideas about content for a drug
prevention intervention.
• Content suggested included effects of drugs on the body, and
the legal consequences of drug possession;
• Specific drugs to focus content on included cannabis, alcohol,
steroids, magic mushrooms and legal highs.
Focus groups with Year
9 students
Explore knowledge and risk perceptions of
drug use and perceptions of drug use
prevalence in their age group. Explore
acceptability and age-appropriateness of drug
education messages on Talk to Frank website.
• Health risks of cannabis are known;
• Legal consequences of cannabis use are less well known;
• Content on impact of drug use on educational achievement
directly, or through school exclusions if caught in possession
needed;
• Content on impact of drug use on parents worrying about harms
(to health, criminal sanctions, schooling exclusions), shame brought
to family, and increasing stress would be welcomed;
• Attention to potential iatrogenic effect of Talk to Frank messages
on amphetamine use promoting weight loss required.
Consultations with stakeholders
(Drug agencies and professionals
who work with young people)
Explore awareness of drug education
resources and support, and views on
appropriate content for a drug prevention
intervention.
• Cannabis and alcohol are the most commonly used drugs by
13 to 14 year olds;
• New Psychoactive Substances (NPS) are an increasing concern,
particularly synthetic cannabinoids; but not in 13 to 14 year olds;
• Staff from drug agencies noted a local problem with anabolic
steroids regarding attendance at needle exchange programs.
Use is not in 13–14 year olds;
• Existing drug education for 13–14 year olds is either provided in
classroom-based sessions, or one-off workshops delivered by a
specialist agency or a community police officer;
• There are limited drug education resources available and existing
resources such as ‘drugs box displays’ are expensive. Resources
require regular updates in response to emerging NPS and
changing trends.
Consultations with Year 8
recipients of ASSIST
Explore ideas about peer supporter training and
content for a drug prevention intervention.
• Content suggested included effects of drugs on the body, how
drugs cause ‘highs’, health risks, legal consequences, and harm
minimisation;
• Specific drugs to focus content on included cannabis, solvents,
magic mushrooms, cocaine, speed, mephedrone, legal highs,
and steroids.
Observations of current
ASSIST practice
Identify aspects of the intervention that work
well and could be adapted for use to deliver
a drug prevention intervention and with a
Year 9 population.
• Flexibility in adapting timings and delivery modes to respond to
student engagement is key for successful delivery of training;
• Need for clear objectives noting which are essential to deliver.
Interviews with intervention
delivery team
Identify possible influences on intervention
feasibility and acceptability. For example,
explore aspects of ASSIST that could be
adapted for use to deliver a drug education
intervention and for use with 13–14 year olds,
as well as those which might not lend
themselves to adaptation.
• Intervention activities need to be interactive;
• Successful implementation of intervention requires flexibility in
delivery to meet needs of different groups;
• Some intervention activities required updating (e.g. ASSIST activity
using postcards because peers supporters did not know what
they were);
• Some intervention activities might be too immature for use with
13–14 year olds;
• Delivery of messages about harms of drug use is much more
complex than harms of smoking (more compounds with
different effects);
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Stage two: Co-production
During the co-production process, the intervention
development group reflected on findings from stage
one and used these to inform the adaptation of con-
tent from ASSIST and the development of new con-
tent. The group was participatory and collaborative
and all members were provided with opportunities
to input. This process exploited the intervention de-
livery team’s experience with the setting, target
population, and intervention content. For example,
it was noted during the stage 1 interviews with the
ASSIST team that an important aspect of the
intervention for them was providing the peer sup-
porters with interesting and memorable facts about
smoking that they could use in conversations with
their peers.
“There’s key facts within ASSIST … four thousand
chemicals [in a cigarette], um, sixty to seventy chemicals
cause cancer, and we always get the impotence one as
well. So the boys always remember the erectile
dysfunction.” [T3]
“So if we can give them facts that sort of link into what
they could be talking about with their friends, it makes
it easier for these conversations to happen. In ASSIST,
one of the facts they always remember, is that smoking
could affect your ability to get an erection. That is the
one that sticks with them, and you might not have done
the training for ten weeks, and they will still remember
that.” [T1]
“In ASSIST, we know that young people will leave
knowing the ingredients of a cigarette, long-term,
short-term health effects, is it guaranteed. We know
that you'd go up to any young person that had done
the training and you'd ask them how many ingredients
are in a cigarette and they’d be able to tell you.” [T1]
This was also observed in field notes of the observa-
tions of delivery of the ASSIST intervention made by the
research team. During stage two, the intervention devel-
opment group considered these findings and decided to
adapt information from the Talk to Frank website [29]
about the risks of drug use into memorable factual
Table 1 Results from application of the 3-stage framework for co-production and prototyping in the ASSIST + Frank study
(Continued)
• Concerns around amount of knowledge required to deliver drug
prevention intervention.
Stage 2: Co-production
Meetings of the intervention
development group
Action research cycle of assessment, analysis,
feedback and agreement on the core
components of the intervention required to
educate peer supporters on the harms of drug
use and the skills required to communicate
these to their peers.
• Findings from Stage 1 suggested long-term harms to health of
low-levels of cannabis are less definitive than those of smoking;
• Include content on concerns expressed by young people and
harms associated with drug use that they did not know about;
• Shift focus towards these concerns and away from harms to
health of the most commonly used drug - cannabis;
• Highlight the potential immediate harms to health from use of
glues, gasses and aerosol (i.e. sudden sniffing death);
• Harms associated with drugs being unregulated and illegal:
unknown compound and dose, thus unexpected effects are likely;
• Potential consequences of sanctions imposed by schools
(temporary, permanent exclusion) and poorer educational
achievement;
• Potential consequences of criminal sanctions on travel and
future career options;
• Mention harms including increasing parental anxiety, stress and
shame;
• Draft intervention manuals and associated resources detailing
intervention activities and how these should be delivered were
produced.
Stage 3: Prototyping
Expert review of intervention
materials
Identify potential problems or weaknesses in
intervention materials prior to piloting.
• Updating of some intervention activities was welcomed;
• More detail needed in instructions for delivery team;
• Refining of timings for some intervention activities.
Testing of intervention
materials with young people
Delivery of intervention. Identification of issues
around feasibility and acceptability of newly
developed intervention content.
• Intervention activities were well received;
• Refinements included amending wording, providing more
detailed instruction and objectives, and using smaller groups.
Training of intervention
delivery team
Simulation of intervention delivery. Identify issues
around feasibility and acceptability of intervention
content.
• Need for additional drug education training;
• Refinements included amending timings, clarifying ambiguities
in instructions, changing format of delivery, adding extra content
and removing content.
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statements. These key statements were then used across
several activities within the peer supporter training and
added to the peer supporter diaries as a reminder.
Examples of the statements include; “Cannabis contains
some of the same chemicals as tobacco”, “A drugs-
related conviction can stop you from travelling to some
countries, such as the USA” and “Giving cannabis to
your mates is considered ‘supplying’ under the law”.
Both the research and ASSIST teams independently
developed adaptations and new content which were
shared amongst the group. For example, a member of
the ASSIST team had already developed a new mode of
delivery for one of the training day activities in ASSIST
in order to address an existing feasibility issue. This was
incorporated into the adapted activity for the new
interventions.
Stage three: Prototyping
A period of prototyping of the intervention content, ma-
terials and delivery methods is a necessary next step for
identifying early issues with acceptability, feasibility and
other potential teething problems so that these can be
addressed prior to formal piloting and evaluation.
Expert peer review of intervention content or compo-
nents is useful for examining key uncertainties that have
been identified during development. Expert reviewers
should be selected based on the areas of greatest of un-
certainty and be independent of the intervention devel-
opment group. There were two areas of uncertainty
identified during the development of +Frank and Frank
friends; how newly developed activities fit with the diffu-
sion of innovations theory, and whether the format of
activities was age-appropriate and followed suitable tim-
ings and sequencing.
We sought expert feedback from the lead author of
the ASSIST RCT [21] to examine fit with theory and
from the lead trainer at DECIPHer Impact who delivers
all training to new ASSIST teams to advise on timings
and sequencing. The feedback received included possible
minor refinements to the timing of some intervention
activities and the presentation of instructions in the
intervention manual. In addition it was suggested that
consideration was given to ‘future proofing’ intervention
resources by identifying content that may require regular
review and updating.
Testing delivery of the draft intervention content or
components on a small scale is also recommended.
Where possible the intervention should be delivered to a
sample of the target population, if not it is advisable to
make use of opportunities for simulated delivery. During
testing, data should be collected to explore the experi-
ences of those delivering the intervention as well as
those receiving it in order to inform refinements.
Table 2 shows an example of how intervention content
was co-produced over each stage of the framework, in-
cluding how the iterative process of gathering feedback
and making refinements was made during the prototyp-
ing stage in response to delivery of an activity from the
peer supporter training. The objective of the activity
(titled ‘What is a drug?’) is to define, name and categor-
ise the effects of drugs. A series of insights were gener-
ated from testing out delivery with a group of young
people, as well as during training of the intervention de-
livery team, where the trainees practised delivery of
intervention activities with each other. Without this
period of testing, these issues would not have emerged
until formal piloting. These included: trainers being anx-
ious they would have to have an encyclopaedic know-
ledge about drugs after young people generated over
thirty names of drugs in the test phase; underestimating
the time taken to list drugs during the activity; and con-
fusions over drugs with a dual effect. Refinements were
made to the training manuals and activities were
amended to address these findings and the content was
tested again.
Reflections on co-production
Interviews with the ASSIST team at the end of stage
three suggested they believed co-production created a
sense of ownership and buy-in of the intervention, which
they were going to be delivering as part of the study:
‘Oh I really enjoyed it, I think it was very beneficial,
especially because if, we’re the ones that’ll be ending
up delivering it’ [T1]
‘It’s good that you know, I can say that I’ve kind of
contributed towards developing something new’ [T2]
‘. . . The team appreciate being asked as well because
you know in the future if we are expected to deliver,
knowing that we’ve been part of it from the start really
does help’ [T4]
Throughout co-production the intervention delivery
team had been able to convey the realities of delivering
interventions to young people and had highlighted im-
portant potential barriers to implementation which were
addressed at an early stage.
‘I think it’s helped to have us involved, just because
we’ve got the hands-on experience of working with
young people’ [T5]
Independent observations by the research team of de-
livery of the finalised intervention identified that some
trainers continued to adapt activities during delivery,
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after co-production had ended. In the +Frank interven-
tion, across the 15 activities, five were delivered in full,
eight had minor deviations from the manual and two
were not delivered at all. In the Frank friends interven-
tion, across the 25 activities, 13 were delivered in full,
nine had minor deviations and three were not delivered
at all. Field notes suggested the delivery team struggled
to switch off from an intervention development mind-
set even after co-production had ended. If carried
through to formal piloting, the interventions may not be
delivered entirely as intended which may potentially be a
barrier to implementation with high fidelity.
Discussion
The three-stage framework presented extends current
guidance by providing pragmatic guidance on how to
co-produce and prototype public health intervention
content and delivery methods before formal piloting. It
provides a framework to guide co-production with stake-
holders so that intervention content is tailored to the
population and setting in order to address implementa-
tion issues at the design stage. This is complementary to
existing intervention development guidelines which pro-
vide information about the use of mapping techniques
[1, 5, 7, 10], intervention theory development [2, 6, 9]
and testing [3, 8]. Our framework offers insight into
how collaboration and co-production with stake-
holders can be incorporated into these stages of inter-
vention development.
The incorporation of stages of co-production and
prototyping builds on existing literature on Transdisci-
plinary Action Research [5, 12] as well as theories of
capacity building noted in community psychology [32],
participatory action-research [33], plan-act-study-do cy-
cles in clinical settings [34, 35], and the use of quality
improvement replications to improve systems [36]. The
involvement of key stakeholders in the co-production of
intervention content provides a mechanism for tailoring
intervention content to the context and target popula-
tion to maximise acceptability and reduce the likelihood
of problems with implementation. A variety of stake-
holders should be engaged to ensure that a range of ex-
pertise and perspectives relevant to the realities of the
intervention problem, target population, and intended
delivery setting is represented.
The case study presented here provides an example of
co-production with key stakeholders throughout the life-
cycle of intervention development to adapt content from
an existing effective peer-led smoking prevention inter-
vention to co-produce two new peer-led drug prevention
interventions. Based on this experience we offer some
reflections on the benefits and potential weaknesses of
such an approach.
Benefits of co-production
The involvement of stakeholders with knowledge and
experience of existing interventions, the target popula-
tion, and the delivery setting has the purpose of maxi-
mising the acceptability, feasibility and quality of the
intervention being developed and its fit with the imple-
mentation context. For example, frontline practitioners
know the delivery setting, as well as issues that have af-
fected the implementation of previous interventions. In
addition, co-production engenders an element of ‘buy-
in’ to the intervention and creates a sense of ownership
amongst those involved in its development. This can be
particularly useful where the intended intervention
Table 2 Example of co-production and prototyping of
intervention content in ASSIST+Frank
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deliverers can be identified at the development stage and
invited to be involved in the intervention development
process. In addition, the involvement of the intended
intervention recipients during co-production can help to
ensure that intervention content meets their needs and
is acceptable and credible.
Weaknesses of co-production
The co-production process is both iterative and fluid.
However, there must come a stage in the process where
intervention content is consolidated and put to the test.
Observations of delivery found that some staff made
amendments to activities, after it was agreed that co-
production had ended and the intervention manual fina-
lised. This meant that out of 40 activities 17 (42.5%)
were delivered with a minor deviation from the instruc-
tions in the manual and five (12.5%) were not delivered
at all. This suggests it may be difficult for stakeholders
to demarcate when the co-production process has
ended, which may be a threat to fidelity if carried
through to formal delivery outside of piloting.
There are several potential barriers to co-production in-
cluding competing priorities and goals and interdisciplin-
ary conflict between the stakeholders involved in the
intervention development process. This is more likely
when the stakeholders involved are from a range of back-
ground fields, bridging both professional and lay perspec-
tives [12]. Another potential barrier is the time consuming
nature of co-production which requires active engagement
from those involved over an indeterminate amount of
time to allow the process to unfold and evolve. Some
stakeholders may not have the flexibility within their roles
that the PHW ASSIST team had so may not be so heavily
involved. There may be some potential limits to the trans-
ferability of this approach for the development of other
public health interventions. The framework was used to
adapt an existing intervention with a strong evidence base
and a well-established delivery structure. In addition, the
PHW ASSIST team were highly experienced in terms of
knowledge and delivery of ASSIST to the target popu-
lation. These conditions may have contributed to the
successful application of the framework within this
study.
Conclusions
The framework presented here provides pragmatic in-
struction on how to coproduce and prototype public
health interventions. It complements other intervention
development guidance by providing more detail on the
process of the early stages of intervention development
and co-production that receives limited attention in
existing guidance on intervention development [1–12].
Future studies should explore its utility in guiding the
process of co-production of interventions with different
target behaviours, populations and stakeholder groups.
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